Market Updates

Trader’s Buzzer: Ariad Pharmaceuticals, Inc (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) share price soared 0.08% or 0.02 points to reach at $23.70 during previous trading session. The stock’s price fluctuated within the range of $23.65 – $23.73 during previous trading session. A total of 35.80M shares exchanged hands, whereas the company’s average trading volume stands at 10.62M shares. Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) has a market capitalization of $4.59B and most recently 194.20M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) is at 90.66.

According to sentiments of 8 analysts the mean estimates of short term price target for the company’s stock is marked at $20.38. The most optimistic analyst sees the stock reaching $24 while the most conventional predicts the target price at $14.

The consensus mean EPS for the current quarter is at $-0.18 derived from a total of 9 estimates. According to analysts minimum EPS for the current quarter is expected at $-0.21 and can go high up to $-0.12. However a year ago during same quarter Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) reported $-0.32 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $-0.17 per share according to consensus of 5 analysts.

According to sentiments of 10 analysts the company is expected to report revenues of $45.61M for the current quarter. Bearish revenue estimates established at $42.5M while the bullish revenue forecast has been figured out at $58.8M

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.56 on the shares of Ariad Pharmaceuticals, Inc (NASDAQ:ARIA). Out of rating recommendations 1 have given the stock a Buy while 2 recommend the stock as Outperform. 6 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Ariad Pharmaceuticals, Inc (NASDAQ:ARIA)’s distance from 20 day simple moving average is 73.83% whereas its distance from 50 day simple moving average is 86.55% along with 136.96% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) shares were trading -0.46% below from the 52-week high mark of $23.81 and 442.33% above from the 52-week bottom of $4.37. The stock hit its 52-week high price on 01/09/17 and 52-week low price on 2/11/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 81.47% in the past one week and soared 86.91% during previous one month drive, the stock went up 73.75% during past quarter. In the last six months the stock’s performance soared 231.93% while yearly performance of the company advanced 307.22%.The company’s year to date (YTD) performance is at 90.51%.

While taking a glance at financials, we can look at a number of key indicators. Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) has a Return on Assets (ROA) of -5.40%. The company currently has a Return on Equity (ROE) of 37.10% and a Return on Investment (ROI) of -62.90%. Average true range (ATR-14) of the company sets at 1.05, along with its weekly and monthly volatility of 2.06%, 3.10% respectively. Beta value of the stock stands at 1.09.

The company’s quick ratio for most recent quarter is 3.20 along with current ratio for most recent quarter of 3.20.

Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *

0 Shares
Share
Tweet
Share
Pin
Stumble
+1